India to New Zealand: Lisinopril Export Trade Route
India has recorded 45 verified shipments of Lisinopril exported to New Zealand, representing a combined trade value of $948.1K USD. This corridor is served by 2 active Indian exporters, with an average shipment value of $21.1K USD. The leading Indian exporter is IPCA LABORATORIES LIMITED, which accounts for 85% of total export value with 38 shipments worth $801.2K USD. On the buying side, NA is the largest importer in New Zealand with $457.9K USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to New Zealand Lisinopril corridor is one of India's established pharmaceutical export routes, with 45 shipments documented worth a combined $948.1K USD. The route is dominated by IPCA LABORATORIES LIMITED, which alone accounts for roughly 85% of all export value, reflecting the consolidated nature of India's lisinopril manufacturing sector.
Across 2 active suppliers, the average shipment value stands at $21.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 72% of all shipments, consistent with lisinopril's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 16 days port-to-port. The route has recorded an annual growth rate of 32.0%, placing it at rank #6 among India's top lisinopril export destinations globally.
On the import side, key buyers of Indian lisinopril in New Zealand include NA, TO THE ORDER, TEVA PHARMA (NEW ZEALAND) LIMITED and 2 others. NA is the single largest importer with 16 shipments valued at $457.9K USD.
Route Characteristics
- Average transit16 days
- Peak seasonQ3
- Primary modeSea freight
- Top portJNPT/ NHAVA SHEVA SEA
Market Position
- Global rank#6
- Annual growth+32.0%
- Demand growth+28.5%
- Regulatory ease73/100
Top 10 Indian Lisinopril Exporters to New Zealand
Showing top 10 of 2 Indian suppliers exporting Lisinopril to New Zealand, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | IPCA LABORATORIES LIMITED Avg $21.1K per shipment | 38 | $801.2K | 84.5% |
| 2 | IPCA LABORATORIES LIMITED Avg $21.0K per shipment | 7 | $146.9K | 15.5% |
This table shows the top 10 of 2 Indian companies exporting lisinopril to New Zealand, ranked by total trade value. The listed exporters are: IPCA LABORATORIES LIMITED, IPCA LABORATORIES LIMITED . IPCA LABORATORIES LIMITED is the dominant supplier with 38 shipments worth $801.2K USD, giving it a 85% market share.
Top 10 Lisinopril Importers in New Zealand
Showing top 10 of 5 known buyers in New Zealand receiving Lisinopril shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian lisinopril in New Zealand include NA, TO THE ORDER, TEVA PHARMA (NEW ZEALAND) LIMITED , STREET AUCKLAND CENTRAL, TEVA PHARMA NEW ZEALAND LIMITEDLEVEL. The largest importer is NA, accounting for $457.9K USD across 16 shipments — representing 48% of all lisinopril imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | NA | 16 | $457.9K | 48.3% |
| 2 | TO THE ORDER | 20 | $245.5K | 25.9% |
| 3 | TEVA PHARMA (NEW ZEALAND) LIMITED | 4 | $107.1K | 11.3% |
| 4 | STREET AUCKLAND CENTRAL | 3 | $101.2K | 10.7% |
| 5 | TEVA PHARMA NEW ZEALAND LIMITEDLEVEL | 2 | $36.4K | 3.8% |
Top 10 Lisinopril Formulations Imported by New Zealand
Showing top 10 of 30 product formulations shipped on the India to New Zealand Lisinopril route, ranked by trade value
New Zealand imports a wide range of lisinopril formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — LISINOPRIL 10 MG (LISINOPRIL TABLETS 10MG) (42620X6X15'S PACK=3835800 TABLETS) — accounts for $79.6K USD across 1 shipments. There are 30 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | LISINOPRIL 10 MG (LISINOPRIL TABLETS 10MG) (42620X6X15'S PACK=3835800 TABLETS) | 1 | $79.6K | 8.4% |
| 2 | HARMLESS MEDICINES Lisinopril 20mg Tablets (Lisinopril Tablets 20 mg) (6x15s)(32050X6x15s PACK) UNIT RATE NZD 4.07354 | 1 | $77.3K | 8.1% |
| 3 | Lisinopril 20mg TabletsLisinopril Table | 2 | $76.7K | 8.1% |
| 4 | Lisinopril 10mg Tablets Lisinopril Tabl | 2 | $64.4K | 6.8% |
| 5 | Lisinopril Tablets 20mg(21430x6x15's Pac | 1 | $52.0K | 5.5% |
| 6 | Lisinopril 20 mg Lisinopril Tablets 20mg20790x6x15's Pack = 1871100 Tablets | 1 | $48.5K | 5.1% |
| 7 | Lisinopril 5mg TabletsLisinopril Tablet | 3 | $47.8K | 5.0% |
| 8 | LISINOPRIL 10MG TABLETS LISINOPRIL TABL | 2 | $47.8K | 5.0% |
| 9 | Lisinopril 10mg (Lisinopril Tablets 10mg)(20952x6x15's Pack=1885680 Tablets) | 1 | $36.6K | 3.9% |
| 10 | Lisinopril 20mg (Lisinopril Tablets 20mg)(15984x6x15's Pack=1438560 Tablets) | 1 | $36.0K | 3.8% |
Showing top 10 of 30 Lisinopril formulations imported by New Zealand on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 72%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
JNPT/ NHAVA SHEVA SEA handles the highest volume with 14 shipments. Transit time averages 16 days by sea.
Market Dynamics
India's lisinopril exports to New Zealand are driven primarily by a handful of large-scale manufacturers. IPCA LABORATORIES LIMITED with 38 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in New Zealand benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — IPCA LABORATORIES LIMITED, IPCA LABORATORIES LIMITED — together account for 100% of total trade value on this route. The average shipment value of $21.1K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as harmless medicines lisinopril 20mg tablets (lisinopril tablets 20 mg) (6x15s)(32050x6x15s pack) unit rate nzd 4.07354 and lisinopril 20mg tabletslisinopril table, suggesting that buyers in New Zealand tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, NA is the largest importer with 16 shipments worth $457.9K USD — representing 48% of all lisinopril imports from India on this route.
Route Statistics
- Trade Volume
- $948.1K
- Avg. Shipment
- $21.1K
- Suppliers
- 2
- Buyers
- 5
- Transit (Sea)
- ~16 days
- Annual Growth
- +32.0%
Related Analysis
Other Lisinopril Routes
Unlock the Full India to New Zealand Lisinopril Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 45 shipments on this route.
Frequently Asked Questions — India to New Zealand Lisinopril Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Lisinopril to New Zealand?
The leading Indian exporters of Lisinopril to New Zealand are IPCA LABORATORIES LIMITED, IPCA LABORATORIES LIMITED . IPCA LABORATORIES LIMITED holds the largest market share at approximately 85% of total trade value on this route.
Q What is the total value of Lisinopril exports from India to New Zealand?
India exports Lisinopril to New Zealand worth approximately $948.1K USD across 45 recorded shipments. The average value per shipment is $21.1K USD.
Q Which ports does India use to ship Lisinopril to New Zealand?
The most active port of origin is JNPT/ NHAVA SHEVA SEA with 14 shipments. Indian exporters primarily use sea freight for this route, with 72% of shipments going by sea and 20% by air.
Q How long does shipping take from India to New Zealand for Lisinopril?
The average transit time for Lisinopril shipments from India to New Zealand is approximately 16 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to New Zealand Lisinopril trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 32.0% with demand growth tracking at 28.5%. The route is ranked #6 among India's top Lisinopril export destinations globally.
Q How many suppliers are active on the India to New Zealand Lisinopril route?
There are currently 2 active Indian suppliers exporting Lisinopril to New Zealand. The market is moderately concentrated with IPCA LABORATORIES LIMITED accounting for 85% of total shipment value.
Q Who are the main importers of Lisinopril from India in New Zealand?
The leading importers of Indian Lisinopril in New Zealand include NA, TO THE ORDER, TEVA PHARMA (NEW ZEALAND) LIMITED , STREET AUCKLAND CENTRAL, TEVA PHARMA NEW ZEALAND LIMITEDLEVEL. NA is the largest buyer with 16 shipments worth $457.9K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to New Zealand export trade corridor identified from Indian Customs (DGFT) records for Lisinopril.
- 2.Supplier/Buyer Matching: 2 Indian exporters and 5 importers in New Zealand matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 45 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
45 Verified Shipments
2 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists